Does ROSUVASTATIN Cause Rectal haemorrhage? 190 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Rectal haemorrhage have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.5% of all adverse event reports for ROSUVASTATIN.
190
Reports of Rectal haemorrhage with ROSUVASTATIN
0.5%
of all ROSUVASTATIN reports
1
Deaths
40
Hospitalizations
How Dangerous Is Rectal haemorrhage From ROSUVASTATIN?
Of the 190 reports, 1 (0.5%) resulted in death, 40 (21.1%) required hospitalization, and 4 (2.1%) were considered life-threatening.
Is Rectal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Rectal haemorrhage?
RIVAROXABAN (4,501)
ASPIRIN (3,057)
ADALIMUMAB (2,629)
VEDOLIZUMAB (2,163)
INFLIXIMAB (1,554)
CLOPIDOGREL BISULFATE (1,333)
APIXABAN (1,177)
WARFARIN (1,174)
PREDNISONE (1,098)
MESALAMINE (990)
Which ROSUVASTATIN Alternatives Have Lower Rectal haemorrhage Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN